Release The Power Of Precise Proteomics
Accelerating proteomics-driven precision medicine
Precision Biomarker Laboratories, a commercial contract research organization (CRO) wholly owned by Cedars-Sinai Medical Center, provides complete proteomics solutions across biomarker discovery, validation and CAP/CLIA-certified laboratory testing capabilities. Our customized workflows allow for the quick translation from protein discovery to clinically validated targeted panels.
Innovative and Integrated Solutions
Accelerate your breakthrough
drugs and diagnostics
Drug Discovery
Pre-Clinical Studies
Diagnostics
Our Services
Discovery Proteomics
Targeted Proteomics
Translational Proteomics
Expanded Technologies and Solutions
The proteome is a dynamic indicator of health
Unlike the genome, the proteome changes over time and throughout the life builds up a tremendous complexity. From around 22000 human genes, more than a million proteoforms are translated, forming a dynamic pool of indicators for health and illness.
Proteomics provides valuable data:
Analyzing the proteome provides multiple layers of information about proteins like expression, function, structure, subcellular location, post-translational modifications (PTMs) and protein-protein interactions.
Combining layers of proteome knowledge reveal insights into:
- Impact of disease triggers
- Mechanism of a disease
- Treatment opportunities and intervention